nents of the signaling pathway activated by cytokines the fate decisions made by defined progenitor cells dursuch as LIF/CNTF, which can promote astrocyte differing development must be followed. This is difficult to entiation (Bonni et al., 1997). Binding of CNTF to its do in vivo and is complicated by the fact that during receptor activates an associated tyrosine kinase, the development progenitor cells are exposed to complex Janus kinase (JaK1), which phosphorylates the STAT environmental cues that influence cell fate decisions, proteins, resulting in their translocation to the nucleus hampering attempts to tease apart the mechanisms (Leonard and O'Shea, 1998). In order for STAT proteins contributing to any given fate choice. Recent advances to activate expression of target genes, such as GFAP, in neural stem cell research have made it possible to they must bind to the transcriptional coactivator CBP/ explore the mechanisms regulating progenitor cell difp300. Sun et al. (2001) found that Ngn1 also binds to ferentiation by analyzing these events in vitro. Multipo-CBP/p300 and can prevent this essential coactivator tent progenitor cells in culture can differentiate to give from associating with the STAT proteins, thus blocking rise to neurons, astrocytes, and oligodendrocytes, simiactivation of glial-specific genes. The ability of ngn1 to lar to what has been observed for multipotent progenitor sequester CBP/p300 was independent of its ability to bind DNA, explaining how the glial inhibitory activity of ngn1 could be uncoupled from its ability to promote *
neurogenesis. Ngn1 was also found to inhibit phosphorylation of the STAT proteins through an unknown mechanism, suggesting that multiple mechanisms may be used by ngn1 to inhibit gliogenesis.
Lif/CNTF can also synergize with bone morphogenetic proteins (BMPs) to promote astrocyte differentiation (Nakashima et al., 1999). BMP signaling by receptor binding leads to phosphorylation of Smad proteins, which then translocate to the nucleus. Smad1 binds to CBP/p300, which also interacts with STAT proteins, thus Smad1 is recruited to glial promoters through its indirect association with STAT proteins. In contrast, BMP stimulation of cortical progenitors in which ngn1 is expressed elicits neuronal differentiation. In this case, the CBP/ p300-Smad1 complex preferentially interacts with ngn1 to induce neurogenesis at the expense of gliogenesis (Sun et al., 2001). Once again, the ability of ngn1 to sequester CBP/p300 and associated proteins has an inhibitory effect on gliogenesis.
Based upon these results, it is reasonable to propose that CBP/p300 is limiting in cortical progenitor cells, thus precluding neurogenesis and gliogenesis from occurring simultaneously. This model suggests that when ngn1 is expressed in progenitors during normal development, neurogenesis is actively promoted through activa- isolated progenitors from Mash1/ngn2 double knockout and glia are being generated. However, in extracts from animals and tested for their ability to differentiate in E14 cortex, when ngn1expression is high and neurogenculture. They found a decrease in the proportion of esis is taking place, CBP/p300 was bound to ngn1, but strictly neuronal clones and an increase in the proportion not to STAT3, even though STAT3 was expressed. This of mixed clones that contained both neurons and GFAPargues that CBP/p300 is also limiting with respect to positive astrocytes. In general, these clones were larger endogenous levels of STAT3 and ngn1, although this and consisted of predominantly astrocytes, with only a has not been tested directly. few neurons. The authors concluded that the loss of Loss of bHLH Factors Causes Enhanced Gliogenesis these two bHLH factors increased the probability that Together, these findings suggest a model in which ngn1 cortical progenitors would differentiate into glia. 
